Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  CELL/TISSUE CULTURE SUPPLIES
A Global Strategic Business Report

This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in Millions of US$. The specific product segments analyzed are Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 132 companies including many key and niche players worldwide such as Affymetrix, Inc., AMRESCO, Inc., Analytical Biological Services, BD Biosciences, Cell Culture Technologies, Cell Essentials, Inc., Invitrogen Corporation, Irvine Scientific, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, USB Corp, Vitrolife AB, and Wisent, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3538  PAGES:    490
PRICE:    $3950  DATE:       October 2008
COMPANIES:  132  MARKET DATA TABLES:   131
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  CELL/TISSUE CULTURE SUPPLIES (Complete Report) Pages : 490   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Cell/Tissue Culture Media, Sera and Reagents.....I-3
  
II. EXECUTIVE SUMMARY79$2250
  1. Market Dynamics.....II-13 $500  
   Outlook .....II-1
Biopharmaceutical Drugs Fuel Cell Culture Market.....II-1
Market Scenario.....II-1
Industrial vs. Academic.....II-1
1$100
   Segmental Outlook.....II-2
Global Market Analysis.....II-2
1$100
   Analysis by Region.....II-3
Analysis by Product Segment.....II-3
Market Structure.....II-3
Leading Players.....II-3
Table 1: Leading Players in US Cell/Tissue Culture Market (2003, 2004, & 2005): Percentage Breakdown of Value Sales for Invitrogen, JRH Biosciences, Hyclone, Cambrex Bio Science Walkersville (Formerly BioWhittaker), Sigma-Aldrich, and Others (includes corresponding Graph/Chart).....II-3
1$300
  2. Trends and Issues.....II-47 $500  
   Surging Demand for Cell Culture Products.....II-4
Stem Cells and Vaccines – Key Drivers.....II-4
Growing Acceptance for Hi-Veg Culture Media.....II-4
1$100
   Fed-Batch Cultures – a Big Hit with Large-Scale Bioprocessors.....II-5
Changing Trend Towards Serum-Free Media.....II-5
Proteomics and Pharmacokinetics to Drive Market Growth.....II-5
1$100
   Bioresearch and Cell Culture in Protein-Based Drug Development.....II-61$100
   CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture.....II-7
Sluggish Fetal Bovine Serum Market.....II-7
Cell Therapy Market Witnesses Increasing Consolidation Activity.....II-7
Specialty Media Growing in Demand.....II-7
1$100
   Emerging Alternatives to Conventional Serum Supplemented Media.....II-8
Growth of Defined Media.....II-8
Regulations Prompt Change in Trends.....II-8
Media Optimization.....II-8
1$100
   Cell-Line Engineering Vs. Cell Culture Media.....II-9
Other Trends.....II-9
Underlying Threat to Cell Culture Industry.....II-9
Manufacture-on-Demand: Gaining Momentum.....II-9
Move Towards Contract Manufacturing.....II-9
1$100
   Factors Impacting Growth.....II-10
Business Models Driving the Need for Contract Manufacturing.....II-10
Trends in Contract Manufacturing.....II-10
Target Sectors for Contract Manufacturers.....II-10
1$100
  3. End Use Analysis.....II-114 $400  
   End Use Applications.....II-11
Cell Therapy.....II-11
Growing by Leaps and Bounds.....II-11
1$100
   Cell Therapy Applications.....II-12
Key Factors Affecting the Cell Therapy Market.....II-12
Future Trends.....II-12
Related Market Sectors.....II-12
Progenitor Cell Therapy.....II-12
1$100
   Table 2: US Market for Progenitor Cell Therapy in the Recent Past (2003 & 2004): Annual Sales in US$ Million for Blood Cells; Skin, Bone and Cartilage; and Others (includes corresponding Graph/Chart).....II-13

Table 3: US Market for Progenitor Cell Therapy in the Recent Past (2003 & 2004): Percentage Breakdown by Value Sales for Blood Cells; Skin, Bone and Cartilage; and Others (includes corresponding Graph/Chart).....II-13
Stem Cell Therapy.....II-13
1$300
   Scope and Applications.....II-14
Other Related Technologies.....II-14
Somatic Cell Nuclear Transfer (SCNT).....II-14
Tissue Engineering.....II-14
End Use Industries.....II-14
1$100
  4. Cell/Tissue Culture: Physiological Overview.....II-1519 $800  
   Introduction.....II-15
History.....II-15
3$300
   Plant Cell and Tissue Culture (PCTC).....II-184$400
   Cell/Tissue Culture Media, Sera and Reagents.....II-22
Classical Media.....II-22
Specialty Media.....II-22
1$100
   Serum.....II-23
Fetal Bovine Serum.....II-23
Serum-Free Media.....II-23
Cell Culture Reagents.....II-23
Role of Tissue Culture in the Growth of Cell Types.....II-23
1$100
   Equipment.....II-24
Storage and Preservation.....II-24
Maintenance.....II-24
Growth Pattern.....II-24
1$100
   Harvesting.....II-25
Media and Growth Requirements.....II-25
Physiological Parameters.....II-25
Medium Requirements (Often Empirical).....II-25
1$100
   Feeding.....II-26
Safety Precautions.....II-26
Methods of Tissue Culture.....II-26
Preparation of Media.....II-26
Growth and Morphology.....II-26
1$100
   Sub Culturing Adherent Cells.....II-27
Trypsin-EDTA.....II-27
EDTA Alone.....II-27
Thawing Frozen Cells.....II-27
Freezing Cells.....II-27
1$100
   Cell Culture Contamination – A Looming Problem.....II-28
Classification.....II-28
Major Cell Culture Contaminants.....II-28
Chemical Contamination.....II-28
Types and Sources of Potential Chemical Contaminants.....II-28
1$100
   Varied Sources of Chemical Contamination.....II-29
Media and Components.....II-29
Sera.....II-29
Water.....II-29
1$100
   Storage Vessels.....II-30
Fluorescent Lights.....II-30
Endotoxins.....II-30
Incubators.....II-30
1$100
   Biological Contamination.....II-31
Varied Sources of Biological Contamination.....II-31
Mycoplasmas.....II-31
1$100
   Airborne Particles and Aerosols.....II-32
Cross Contamination by Other Cell Cultures.....II-32
Consequences/Problems of Contamination.....II-32
1$100
   Controlling Cell Culture Contamination.....II-33
Measures Aimed at Reducing Contamination Problems.....II-33
1$100
  5. Regulatory Environment.....II-341 $100  
   Regulatory Environment.....II-34
1$100
  6. Product Introductions/Innovations.....II-3512 $800  
   Millipore Releases New Primary Human Epithelial Cell Cultures.....II-35
Millipore Expands Stem Cell Tested Initiative.....II-35
BD Biosciences Debuts BD FACSAria™ II System to Sort Cells.....II-35
1$100
   Invitrogen Introduces Specific SFM for the Mesenchymal Stem Cells.....II-36
StemCell Launches Cryopreservation Medium Free from Serum.....II-36
Invitrogen Unveils SequalPrep™ System.....II-36
Invitrogen Introduces Animal Source-Free Substrate.....II-36
Invitrogen Introduces GIBCO® FoamAway™ Reagent.....II-36
1$100
   Genetix Develops New CytoGenetix Reagents and Kits.....II-37
Thermo Fisher Launches NUNC In Vitro PDL Coated PETG Roller Bottles.....II-37
Thermo Fisher Scientific Introduces HyClone AdvanceSTEM™ Cell Culture Product
  Line.....II-37
1$100
   Thermo Fisher Scientific Introduces New Medium to Culture PER.C6 Cell Line.....II-38
Genetix Expands CloneMedia Semi-Solid Media Products.....II-38
Invitrogen Launches STEMPRO® EZPassage™ Tool.....II-38
Sigma-Aldrich Introduces GenomePlex Tissue WGA Kit.....II-38
1$100
   Thermo Fisher Scientific Introduces Two New Versatile Media for HEK 293 Cell
  Line.....II-39
SAFC Biosciences Launches LONG®R3IGF-I in Liquid Form.....II-39
Invitrogen and Novocell Introduce Media for hESC Growth.....II-39
Invitrogen Releases New Culture System.....II-39
1$100
   Invitrogen Introduces New Line of Engineered Stem Cells.....II-40
BD Biosciences Partners with StemCell Technologies.....II-40
Millipore Launches MEL Cell Lines.....II-40
Irvine Scientific Expands Industrial Cell Culture Product Line.....II-40
1$100
   Biovest International Introduces Automated Cell Culture Device.....II-41
BD Biosciences Introduces BD FACSDiva™ 6.0 Software.....II-41
Millipore Unveils Nylon Net Steriflip® Filter Unit.....II-41
Lonza Expands Product-Portfolio with Serum Free Media.....II-41
1$100
   MediCult Unveils Flexible Culture Systems, BlastAssist® and EmbryoAssist™.....II-42
Millipore Introduces New Medium for Human Embryonic Stem Cell Research.....II-42
Invitrogen Launches CytoGenie™ Cytometry Software Tool.....II-42
Novozymes Releases New Cell Culture Components.....II-42
The Automation Partnership Launches Advanced Plating Module.....II-42
1$100
   Nikon Unveils BioStation CT.....II-43
Corning Launches Innovative Cell Culture Solutions.....II-43
GroPep Introduces New Assay Kit for Cell Culture Business.....II-43
HyClone Introduces HyQ®CDM4MAb™ for Hybridoma Cell Lines.....II-43
1$100
   INTEGRA Biosciences Adds Alarm Interface to CELLROLL and CELLSPIN Systems.....II-44
Nikon Launches New Imaging and Tracking Systems for Cell Culture.....II-44
Genetix Develops Cell Dispenser.....II-44
SAFC Biosciences Introduces LONGTMR3IGF-I for Industrial Cell Culture.....II-44
Biocrystal Presents Opticell.....II-44
1$100
   TAP Unveils CompacT SelecT™.....II-45
New Brunswick Scientific Augments New Products to Cell Culture Systems.....II-45
Cell Culture Technologies Develops Fortified Production Media.....II-45
HyClone Unveils New Microcarrier Product Line - HyQ®Spheres™.....II-45
Celliance Brings Out LucraTone(TM) Peptones.....II-45
Millipore Offers More Products for Cell Culture Assays.....II-45
1$100
   FibraStage™ Cell Culture System for Higher Yields.....II-46
Acolyte to Incorporate AK Rapid® technology BacLite RapiTECT™ Range.....II-46
Ventria Bioscience Unveiled Lacromin™ for Cell Culture Media.....II-46
Vivascience Launches Vivadish.....II-46
Celliance Corporation Unveils Hybri-CYTE(TM).....II-46
1$100
  7. Recent Industry Activity.....II-4716 $800  
   Invitrogen Establishes Dedicated Business Unit for Cell Therapy.....II-47
Invitrogen Signs Deal to Acquire CellzDirect.....II-47
Invitrogen Renews Agreement with Luminex Corporation.....II-47
BioTime Establishes Tissue Culture Facility.....II-47
1$100
   International Stem Cell Signs Agreement with ATCC.....II-48
Millipore Signs Agreement with Solabia to Distribute Animal-Free Hydrolysates.....II-48
Affymetrix Acquires USB Corporation.....II-48
SAFC to Expand Production Capacity of Viral Product.....II-48
1$100
   Lonza Signs Partnership Agreement with Sanofi to Produce Cell Culture Vaccine.....II-49
SAFC to Increase Fermentation Capabilities of High-Potency API.....II-49
Biogen Offers Contract to Jacobs Engineering Group.....II-49
New Brunswick Scientific Merges with Eppendorf Group.....II-49
Vitrolife Extends Agreement with Cellartis.....II-49
Sigma-Aldrich Inks Distribution Agreement with CellPath.....II-49
1$100
   Lonza Acquires two Subsidiaries of Cambrex Bio-Businesses.....II-50
Vikdas to Build Biotechnological Laboratory.....II-50
Novartis to Invest in a New Cell Culture Plant in Singapore.....II-50
Invitrogen Signs Agreement with Biocon.....II-50
Lonza and Bio*One form Joint Venture for Mammalian Cell Culture Plant.....II-50
1$100
   Thermo Fisher to Extend Manufacturing Operations.....II-51
BD Biosciences Announces Treyburn Expansion Plans.....II-51
BD Biosciences Collaborates with Roche to Advance Cell Signal Transduction
  Study.....II-51
Invitrogen and RXi Pharmaceuticals Enter into Collaboration.....II-51
1$100
   Millipore Forms a Strategic Alliance with Novozymes.....II-52
Thermo Fisher Takes Over OptiCell Product Line.....II-52
Invitrogen Collaborates with Cytori for Research on Adipose Stem Cell.....II-52
Thermo Fisher Partners with Cellular Engineering for Stem Cell Research.....II-52
1$100
   VWR Signs Agreement to Distribute Biovest’s Cell Culture Device.....II-53
Genentech Constructs New Cell Culture Plant.....II-53
Invitrogen Signs Deal with Wave Biotech to Offer Media-Filled Disposable
  Bioreactors.....II-53
MediCult Purchases Humagen Fertility.....II-53
Millipore Acquires Serologicals.....II-53
1$100
   ReNeuron Inks Collaboration Agreement with CellSeed.....II-54
Trans Valley Launches Tissue Cultured Variety of Mushrooms.....II-54
HiMedia Laboratories Forges Distribution Deal with VWR International.....II-54
Teva Signs Collaboration Agreement with Protalix Biotherapeutics.....II-54
SAFC-Biosciences Forms to Support Sigma-Aldrich.....II-54
1$100
   Invitrogen and Cellartis to Co-develop hESC Reporter Lines.....II-55
CELLCA and Rentschler Join Forces for Unique High-Level Expression System.....II-55
ArcDia Partners with Chip-Man Technologies.....II-55
Chugai Pharmaceutical Receives License for Cell Line from Cambrex Bio Science
  Walkersville, Inc......II-55
Chemicon Inks Distribution Agreement with CELLnTEC.....II-55
1$100
   Chemicon Signs an Agreement with ReNeuron.....II-56
Chemicon to Market Stem Cell Products of ASCC.....II-56
SCS and Chemicon Introduce ESGRO Complete™ Product Range.....II-56
Serologicals Acquires Cytomyx Ltd.....II-56
Millipore to Take Over Serologicals.....II-56
CAT Opts SelectT™ for Higher Cell Culture Yields.....II-56
1$100
   SAFC to Market Cell Line Engineering of ProBioGen.....II-57
Chemicon Licensed to Employ the RheoSwitch(R) System of RheoGene.....II-57
SCS and Chemicon Sign an Agreement for ES Cell Media.....II-57
Innovata Grants UCOE Gene Expression Technology to Celliance.....II-57
Chemicon and Axordia Collaborate for New Antibody Markers.....II-57
Genzyme Acquires Verigen AG.....II-57
1$100
   Chemicon Acquires Specialty Media.....II-58
CalbaTech Pockets K-D Medical.....II-58
Sigma- Aldrich Acquires JRH Biosciences.....II-58
Invitrogen Acquires Dynal.....II-58
1$100
   Invitrogen Takes Over Biosource International.....II-59
CellzDirect Takes Over HepatoTech.....II-59
BD Acquires Atto Biosciences.....II-59
Serologicals Corp Pockets AltaGen Biosciences.....II-59
1$100
   Serologicals Purchases Upstate Group.....II-60
The Automation Partnership (TAP) Collaborates with MAIA SCIENTIFIC.....II-60
Cambrex Bio Science signs agreement with QBM Cell Science.....II-60
Serologicals Forms Celliance.....II-60
JRH Biosciences Opens cGMP Facility.....II-60
1$100
   Vitrolife Bags Patent Approvals in the US and Europe.....II-61
C3 Receives Clearance from Japanese Ministry of Health.....II-61
Fisher Scientific Acquires Perbio Science.....II-61
ICN Pharmaceuticals Divests Biomedicals Division.....II-61
Boston Scientific Enters Into a Strategic Alliance with Osiris.....II-61
2$200
  8. Focus on Select Major Players.....II-635 $500  
   Affymetrix, Inc. (USA).....II-63
AMRESCO Inc (USA).....II-63
Analytical Biological Services (USA).....II-63
BD Biosciences (USA).....II-63
1$100
   Cell Culture Technologies (Switzerland).....II-64
Cell Essentials, Inc. (USA).....II-64
Invitrogen Corporation (USA).....II-64
1$100
   Irvine Scientific (USA).....II-65
Lonza Biologics Plc (UK).....II-65
Mediatech, Inc. (USA).....II-65
Millipore Corporation (USA).....II-65
Medi-Cult A/S (Denmark).....II-65
1$100
   MP Biomedicals (USA).....II-66
PerBio Science AB (Sweden).....II-66
PromoCell GmbH (Germany).....II-66
Sera Laboratories International (UK).....II-66
1$100
   Sigma-Aldrich Corporation (USA).....II-67
SAFC Biosciences (USA).....II-67
USB Corp (USA).....II-67
Vitrolife AB (Sweden).....II-67
Wisent, Inc. (Canada).....II-67
1$100
  9. Global Market Perspective.....II-68   
   Table 4: World Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-681$300
   Table 5: World Long-term Projections for Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-691$300
   Table 6: World 10-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-701$300
   Cell/Tissue Culture Supplies Market by Product Segment.....II-71
Table 7: World Recent Past, Current & Future Analysis for Media Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-71
1$300
   Table 8: World Long-term Projections for Media Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-721$300
   Table 9: World 10-Year Perspective for Media Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-731$300
   Table 10: World Recent Past, Current & Future Analysis for Sera Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-741$300
   Table 11: World Long-term Projections for Sera Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-751$300
   Table 12: World 10-Year Perspective for Sera Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-761$300
   Table 13: World Recent Past, Current & Future Analysis for Reagent Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-771$300
   Table 14: World Long-term Projections for Reagent Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-781$300
   Table 15: World 10-Year Perspective for Reagent Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-791$300
III. MARKET73$1950
  1. The United States.....III-132 $1475  
   A. Market Analysis.....III-1
Biotech Industry in the US.....III-1
Government Sponsors Development of Cell-Based III-1 Technologies for Vaccines.....III-1
Cell & Tissue Culture Market.....III-1
A Brief Insight.....III-1
1$75
   Grade Definitions.....III-2
Market Trends.....III-2
Trend Towards Serum-Free Media.....III-2
1$75
   Table 16: US Market for Cell Culture in the Recent Past (2004): Percentage Breakdown of Value Sales for Media, Sera and Reagents for Industrial End Use Application (includes corresponding Graph/Chart).....III-3

Table 17: US Market for Cell Culture in the Recent Past (2004): Percentage Breakdown of Value Sales for Academic End Use Application for Liquid Media, Powdered Media, Fetal Bovine Serum, Serum-free and Protein-free Media, Growth Factors, Other Sera, Supplements, Antibiotics, and Other Products (includes corresponding Graph/Chart).....III-3
Liquid and Powdered Media Account for Major Share.....III-3
1$150
   Table 18: Leading Players In The Us Cell Culture Media Market (2006): Percentage Breakdown Of Volume Sales For - Hyclone, Sigma-Aldrich, Cambrex, Invitrogen, Jrh, Bd Sciences, and Others (includes corresponding Graph/Chart).....III-4
Fetal Bovine Serum - Uses on a Decline.....III-4
Table 19: Leading Players in the US Cell Culture Serum Market (2006): Percentage Breakdown of Volume Sales for - Invitrogen, Roche, Hyclone, Serological, Sigma-Aldrich, Cambrex, and Others (includes corresponding Graph/Chart).....III-4
1$150
   Table 20: Leading Producers of Fetal Bovine Serum in the US in the Recent Past (2004): Percentage Breakdown of Value Sales for Life Technologies, Hyclone, and Others (includes corresponding Graph/Chart).....III-5
Bovine Serum Industry: Highly Unpredictable.....III-5
Suppliers Searching for New Areas.....III-5
Sustained Rise of Serum-Free and Protein- Free Media.....III-5
Rise in Cell Culture Equipment Demand Leads to Innovation.....III-5
End Use Analysis.....III-5
1$150
   Table 21: US Market for Cell and Tissue Culture in the Recent Past (2004): Percentage Share by Research Application for Cellular Research, Protein Expression, Protein Production, Cell Therapy, and Cell Transplantation (includes corresponding Graph/Chart).....III-6

Table 22: US Market for Cell Culture Reagents in the Recent Past (2004): Percentage Breakdown of Value Sales for End Use Applications- Academic, Industrial, and Non-Academic (includes corresponding Graph/Chart).....III-6
1$150
   Table 23: Leading Players in US Cell/Tissue Culture Market in the Recent Past (2003, 2004, & 2005): Percentage Breakdown of Value Sales for Invitrogen, JRH Biosciences,Hyclone, Cambrex Bio Science Walkersville (Formerly BioWhittaker), Sigma-Aldrich, and Others (includes corresponding Graph/Chart).....III-7
Factors Influencing the Market for Tissue and Cell Culture Media.....III-7
Regulatory Controls.....III-7
Guidelines Governing Use of Cell/Tissue Culture Reagents.....III-7
1$150
   MSDS and Hazardous Information.....III-8
Toxic Substances Control Act.....III-8
Imports & Exports.....III-8
Table 24: US Imports of Preparation Culture Media (2006 & 2007): Imports by Country for Italy, Germany, Canada, UK, France, and Others (US$ Thousand) (includes corresponding Graph/Chart).....III-8
1$150
   Table 25: US Exports of Preparation Culture Media (2006 & 2007): Exports by Country for Belgium, Canada, Japan, UK, Germany, Netherlands, France, and Others (US$ Million) (includes corresponding Graph/Chart).....III-9
Product Launches/Developments.....III-9
9$675
   Strategic Corporate Developments.....III-189$675
   Key Players.....III-274$300
   B. Market Analytics.....III-31
Table 26: US Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-31

Table 27: US Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-31
1$150
   Table 28: US 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-32
1$150
  2. Canada.....III-333 $350  
   A. Market Analysis.....III-33
Current & Future Analysis.....III-33
Biotechnology Industry.....III-33
Imports & Exports.....III-33
Table 29: Canadian Imports of Preparation Culture Media (*) (2006 & 2007): Imports by Country for USA, UK, Germany, Italy, France, Australia, Finland, and Others (in US$ Thousand) (includes corresponding Graph/Chart).....III-33

Table 30: Canadian Exports of Preparation Culture Media (*) (2006 & 2007): Exports by Country for USA, Nigeria, China, UAE, Italy, and Others (in US$ Thousand) (includes corresponding Graph/Chart).....III-33
1$150
   Key Player.....III-34
B. Market Analytics.....III-34
Table 31: Canadian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-34
1$150
   Table 32: Canadian Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-35

Table 33: Canadian 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-35
1$150
  3. Japan.....III-363 $225  
   A. Market Analysis.....III-36
Current & Future Analysis.....III-36
Biotechnology Industry in Japan.....III-36
Product Launch/Development.....III-36
Strategic Corporate Developments.....III-36
1$75
   B. Market Analytics.....III-37
Table 34: Japanese Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-37

Table 35: Japanese Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-37
1$150
   Table 36: Japanese 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-38
1$150
  4. Europe.....III-395 $500  
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
Market Overview.....III-39
Biotech and Life-Science Research.....III-39
1$75
   B. Market Analytics.....III-40
Table 37: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region – France, Germany, UK, Italy & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-40
1$150
   Table 38: European Long-term Projections for Cell/Tissue Culture Supplies by Geographic Region – France, Germany, UK, Italy and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-41

Table 39: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-41
1$150
   Table 40: European Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-42

Table 41: European 10-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-42
1$150
   Table 42: European 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-43
1$150
  4a. France.....III-442 $225  
   Market Analysis.....III-44
Current & Future Analysis.....III-44
Table 43: French Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-44
1$150
   Table 44: French Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-45

Table 45: French 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-45
1$150
  4b. Germany.....III-465 $425  
   A. Market Analysis.....III-46
Current & Future Analysis.....III-46
Biotech Research Scenario.....III-46
1$75
   Table 46: German Biotech Market in the Recent Past (2004): Percentage Breakdown by Application Area – Environment, Human Health Care, Chemical industry, Food, Agriculture, Energy, and Others (includes corresponding Graph/Chart).....III-47
Strategic Corporate Developments.....III-47
1$150
   Key Player.....III-481$75
   B. Market Analytics.....III-49
Table 47: German Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-49

Table 48: German Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-49
1$150
   Table 49: German 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-50
1$150
  4c. The United Kingdom.....III-517 $525  
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
Biotechnology Industry – A Brief Insight.....III-51
Research Entities.....III-51
Commercial Activities.....III-51
Outlook.....III-51
1$75
   Regulatory Issues.....III-52
HFE Act Guidelines.....III-52
The Ethical Issues.....III-52
1$75
   Table 50: Prepared Culture Media Market in the UK (2004-2006): Exports and Imports in Tons and £ Millions (includes corresponding Graph/Chart).....III-53
Product Launches/Developments.....III-53
1$150
   Strategic Corporate Developments.....III-541$75
   Key Player.....III-551$75
   B. Market Analytics.....III-56
Table 51: UK Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-56

Table 52: UK Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-56
1$150
   Table 53: UK 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-57
1$150
  4d. Italy.....III-582 $200  
   Market Analysis.....III-58
Current & Future Analysis.....III-58
Table 54: Italian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-58
1$150
   Table 55: Italian Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-59

Table 56: Italian 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-59
1$150
  4e. Rest of Europe.....III-606 $425  
   A. Market Analysis.....III-60
Current & Future Analysis.....III-60
Scenario in other European Countries.....III-60
Product Launch/Development.....III-60
1$75
   Strategic Corporate Developments.....III-611$75
   Key Players.....III-622$150
   B. Market Analytics.....III-64
Table 57: Rest of Europe Market for Cell/Tissue Culture Supplies – Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-64

Table 58: Rest of Europe Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-64
1$150
   Table 59: Rest of Europe 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-65
1$150
  5. Asia-Pacific.....III-666 $450  
   A. Market Analysis.....III-66
Current & Future Analysis.....III-66
Rise of Cell Culture in Asia.....III-66
India.....III-66
Cell Culture Market Constituents.....III-66
1$75
   China.....III-67
Taiwan.....III-67
Australia.....III-67
Strategic Corporate Developments.....III-67
3$225
   B. Market Analytics.....III-70
Table 60: Asia-Pacific Market for Cell/Tissue Culture Supplies – Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-70

Table 61: Asia-Pacific Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-70
1$150
   Table 62: Asia-Pacific 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-71
1$150
  6. Latin America.....III-722 $300  
   A. Market Analysis.....III-72
Current & Future Analysis.....III-72
Brazilian Biotech Industry.....III-72
B. Market Analytics.....III-72
Table 63: Latin American Market for Cell/Tissue Culture Supplies – Recent Past, Current & Future Analysis by Product Segment for Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-72
1$150
   Table 64: Latin American Long-term Projections for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-73

Table 65: Latin American 10-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-73
1$150
IV. COMPETITIVE LANDSCAPE 322$995
  
Total Companies Profiled: 132 (including Divisions/Subsidiaries - 151)

Region/Country                 Players


The United States                  89  
Canada                              4
Japan                               2
Europe                             45
     France                         2
     Germany                       10
     The United Kingdom            19
     Spain                          1
     Rest of Europe                13
Asia-Pacific (Excluding Japan)      7
Latin America                       1
Middle East                         3
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.